Spranger J - Search Results

1

The many faces of ghrelin: new perspectives for nutrition research?

Otto B, Spranger J, Benoit SC, Clegg DJ, Tschöp MH. Otto B, et al. Among authors: spranger j. Br J Nutr. 2005 Jun;93(6):765-71. doi: 10.1079/bjn20051446. Br J Nutr. 2005. PMID: 16022744 Review.

2

Glucagon inhibits ghrelin secretion in humans.

Arafat MA, Otto B, Rochlitz H, Tschöp M, Bähr V, Möhlig M, Diederich S, Spranger J, Pfeiffer AF. Arafat MA, et al. Among authors: spranger j. Eur J Endocrinol. 2005 Sep;153(3):397-402. doi: 10.1530/eje.1.01981. Eur J Endocrinol. 2005. PMID: 16131602

3

Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels.

Otto C, Otto B, Göke B, Pfeiffer AF, Lehrke M, Vogeser M, Spranger J, Parhofer KG. Otto C, et al. Among authors: spranger j. J Endocrinol Invest. 2006 Mar;29(3):231-6. doi: 10.1007/BF03345545. J Endocrinol Invest. 2006. PMID: 16682836

4

Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans.

Möhlig M, Spranger J, Otto B, Ristow M, Tschöp M, Pfeiffer AF. Möhlig M, et al. Among authors: spranger j. J Endocrinol Invest. 2002 Dec;25(11):RC36-8. doi: 10.1007/BF03344062. J Endocrinol Invest. 2002. PMID: 12553549

5

Post-prandial decrease of human plasma ghrelin in the absence of insulin.

Spranger J, Ristow M, Otto B, Heldwein W, Tschöp M, Pfeiffer AF, Möhlig M. Spranger J, et al. J Endocrinol Invest. 2003 Aug;26(8):RC19-22. doi: 10.1007/BF03347349. J Endocrinol Invest. 2003. PMID: 14669821

6

Glucagon suppression of ghrelin secretion is exerted at hypothalamus-pituitary level.

Arafat AM, Perschel FH, Otto B, Weickert MO, Rochlitz H, Schöfl C, Spranger J, Möhlig M, Pfeiffer AF. Arafat AM, et al. Among authors: spranger j. J Clin Endocrinol Metab. 2006 Sep;91(9):3528-33. doi: 10.1210/jc.2006-0225. Epub 2006 Jun 20. J Clin Endocrinol Metab. 2006. PMID: 16787987

7

Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia.

Otto C, Otto B, Frost RJ, Vogeser M, Pfeiffer AF, Spranger J, Parhofer KG. Otto C, et al. Among authors: spranger j. Acta Diabetol. 2007 Jun;44(2):65-8. doi: 10.1007/s00592-007-0244-8. Epub 2007 May 27. Acta Diabetol. 2007. PMID: 17530469 Clinical Trial.

8

Consuming fructose-sweetened beverages increases body adiposity in mice.

Jürgens H, Haass W, Castañeda TR, Schürmann A, Koebnick C, Dombrowski F, Otto B, Nawrocki AR, Scherer PE, Spranger J, Ristow M, Joost HG, Havel PJ, Tschöp MH. Jürgens H, et al. Among authors: spranger j. Obes Res. 2005 Jul;13(7):1146-56. doi: 10.1038/oby.2005.136. Obes Res. 2005. PMID: 16076983 Free article.

9

Ghrelin is not suppressed in hyperglycemic clamps by gastric inhibitory polypeptide and arginine.

Rudovich NN, Dick D, Moehlig M, Otto B, Spranger J, Rochlitz HJ, Ristow M, Tschoep M, Pfeiffer AF. Rudovich NN, et al. Among authors: spranger j. Regul Pept. 2005 Apr 15;127(1-3):95-9. doi: 10.1016/j.regpep.2004.10.012. Regul Pept. 2005. PMID: 15680475

10

Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36.

Pfluger PT, Kampe J, Castaneda TR, Vahl T, D'Alessio DA, Kruthaupt T, Benoit SC, Cuntz U, Rochlitz HJ, Moehlig M, Pfeiffer AF, Koebnick C, Weickert MO, Otto B, Spranger J, Tschöp MH. Pfluger PT, et al. Among authors: spranger j. J Clin Endocrinol Metab. 2007 Feb;92(2):583-8. doi: 10.1210/jc.2006-1425. Epub 2006 Nov 21. J Clin Endocrinol Metab. 2007. PMID: 17119001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters